SU1138024A3 - Способ получени аминопроизводных пиридазина - Google Patents
Способ получени аминопроизводных пиридазина Download PDFInfo
- Publication number
- SU1138024A3 SU1138024A3 SU823475704A SU3475704A SU1138024A3 SU 1138024 A3 SU1138024 A3 SU 1138024A3 SU 823475704 A SU823475704 A SU 823475704A SU 3475704 A SU3475704 A SU 3475704A SU 1138024 A3 SU1138024 A3 SU 1138024A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- pyridazine
- carbon atoms
- formula
- amine
- water
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- 150000004892 pyridazines Chemical class 0.000 title 1
- -1 PYRIDAZINE AMINO DERIVATIVES Chemical class 0.000 claims abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract 3
- 150000001412 amines Chemical class 0.000 claims abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 3
- 239000001257 hydrogen Substances 0.000 claims abstract 3
- IBWYHNOFSKJKKY-UHFFFAOYSA-N 3-chloropyridazine Chemical compound ClC1=CC=CN=N1 IBWYHNOFSKJKKY-UHFFFAOYSA-N 0.000 claims abstract 2
- 125000002947 alkylene group Chemical group 0.000 claims abstract 2
- 238000009835 boiling Methods 0.000 claims abstract 2
- 125000005843 halogen group Chemical group 0.000 claims abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 2
- 239000002904 solvent Substances 0.000 claims abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 7
- 206010015995 Eyelid ptosis Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 201000003004 ptosis Diseases 0.000 description 5
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 4
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 4
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 4
- 230000001430 anti-depressive effect Effects 0.000 description 4
- 239000000935 antidepressant agent Substances 0.000 description 4
- 229940005513 antidepressants Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 4
- 229960003147 reserpine Drugs 0.000 description 4
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ROVPWRBPJHXFRE-UHFFFAOYSA-N 3-chloro-4-methyl-6-phenylpyridazine Chemical compound N1=C(Cl)C(C)=CC(C=2C=CC=CC=2)=N1 ROVPWRBPJHXFRE-UHFFFAOYSA-N 0.000 description 1
- XQMSOYJVSMNXSV-UHFFFAOYSA-N 3-chloro-6-(4-methoxyphenyl)-4-methylpyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(C)=C(Cl)N=N1 XQMSOYJVSMNXSV-UHFFFAOYSA-N 0.000 description 1
- YBBFPPYFMYGBSU-UHFFFAOYSA-N 4-[6-(2-aminoethylamino)-5-methylpyridazin-3-yl]phenol Chemical compound NCCNC=1N=NC(=CC1C)C1=CC=C(C=C1)O YBBFPPYFMYGBSU-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- IHGHYTVLKPZYEV-UHFFFAOYSA-N n'-(4-methyl-6-phenylpyridazin-3-yl)butane-1,4-diamine Chemical compound N1=C(NCCCCN)C(C)=CC(C=2C=CC=CC=2)=N1 IHGHYTVLKPZYEV-UHFFFAOYSA-N 0.000 description 1
- VIUDAFUCYIXLKN-UHFFFAOYSA-N n'-(4-methyl-6-phenylpyridazin-3-yl)propane-1,3-diamine Chemical compound N1=C(NCCCN)C(C)=CC(C=2C=CC=CC=2)=N1 VIUDAFUCYIXLKN-UHFFFAOYSA-N 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8115380A FR2510998B1 (fr) | 1981-08-07 | 1981-08-07 | Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1138024A3 true SU1138024A3 (ru) | 1985-01-30 |
Family
ID=9261294
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU823475704A SU1138024A3 (ru) | 1981-08-07 | 1982-08-06 | Способ получени аминопроизводных пиридазина |
| SU823476698A SU1140685A3 (ru) | 1981-08-07 | 1982-08-06 | Способ получени замещенных производных пиридазина |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU823476698A SU1140685A3 (ru) | 1981-08-07 | 1982-08-06 | Способ получени замещенных производных пиридазина |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4508720A (OSRAM) |
| EP (2) | EP0074863B1 (OSRAM) |
| JP (2) | JPS5877868A (OSRAM) |
| KR (2) | KR880001624B1 (OSRAM) |
| AR (2) | AR231637A1 (OSRAM) |
| AT (2) | ATE18216T1 (OSRAM) |
| AU (2) | AU548931B2 (OSRAM) |
| CA (2) | CA1174240A (OSRAM) |
| CS (2) | CS229941B2 (OSRAM) |
| DD (2) | DD202549A5 (OSRAM) |
| DE (2) | DE3269383D1 (OSRAM) |
| DK (2) | DK148795C (OSRAM) |
| EG (2) | EG15747A (OSRAM) |
| ES (2) | ES8305737A1 (OSRAM) |
| FI (2) | FI72968C (OSRAM) |
| FR (1) | FR2510998B1 (OSRAM) |
| GR (2) | GR76430B (OSRAM) |
| HU (2) | HU190028B (OSRAM) |
| IE (2) | IE53388B1 (OSRAM) |
| IL (2) | IL66409A (OSRAM) |
| MA (2) | MA19560A1 (OSRAM) |
| NO (2) | NO157861C (OSRAM) |
| NZ (2) | NZ201520A (OSRAM) |
| OA (2) | OA07175A (OSRAM) |
| PH (1) | PH18545A (OSRAM) |
| PL (2) | PL137199B1 (OSRAM) |
| PT (2) | PT75350B (OSRAM) |
| SU (2) | SU1138024A3 (OSRAM) |
| YU (2) | YU171882A (OSRAM) |
| ZA (2) | ZA825512B (OSRAM) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2540113A1 (fr) * | 1983-01-27 | 1984-08-03 | Sanofi Sa | Acides derives de la pyridazine actifs sur le systeme nerveux central |
| US4565814A (en) * | 1983-01-28 | 1986-01-21 | Sanofi | Pyridazine derivatives having a psychotropic action and compositions |
| US4628088A (en) * | 1984-07-17 | 1986-12-09 | Eli Lilly And Company | Preparation of substituted pyridazines |
| EP0190563B1 (de) * | 1985-01-14 | 1989-08-02 | Boehringer Ingelheim Kg | Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung |
| FR2663326B2 (fr) * | 1989-11-17 | 1992-10-16 | Sanofi Sa | Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
| US5461053A (en) * | 1989-02-07 | 1995-10-24 | Sanofi | Pyridazine derivatives |
| FR2665442B1 (fr) * | 1990-07-31 | 1992-12-04 | Sanofi Sa | Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
| FR2642754B1 (fr) * | 1989-02-07 | 1991-05-24 | Sanofi Sa | Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant |
| PT93060B (pt) | 1989-02-07 | 1995-12-29 | Sanofi Sa | Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem |
| US5631255A (en) * | 1989-02-07 | 1997-05-20 | Sanofi | Pyridazine derivatives |
| FR2654727B1 (fr) * | 1989-11-17 | 1992-03-27 | Sanofi Sa | Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
| FR2642648B1 (fr) * | 1989-02-07 | 1991-06-21 | Sanofi Sa | Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique |
| FR2676444B1 (fr) * | 1991-05-16 | 1995-03-10 | Sanofi Elf | Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant. |
| US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
| WO2003018563A1 (en) * | 2001-08-31 | 2003-03-06 | Northwestern University | Anti-inflammatory and protein kinase inhibitor composition and method of use |
| AU2003246979B8 (en) * | 2002-08-13 | 2009-08-06 | Merck Sharp & Dohme Limited | Phenylpyridazine derivatives as ligands for GABA receptors |
| ES2543813T3 (es) | 2004-11-02 | 2015-08-24 | Northwestern University | Compuestos de piridazina para el tratamiento de enfermedades inflamatorias |
| EP1812007B1 (en) * | 2004-11-02 | 2011-09-07 | Northwestern University | Pyridazine compounds and methods |
| CA2650625A1 (en) | 2006-04-28 | 2007-11-08 | Northwestern University | Formulations containing pyridazine compounds for treating neuroinflammatory diseases |
| US20100168120A1 (en) * | 2006-04-28 | 2010-07-01 | Neuromedix Inc. | Salts of pyridazine compounds |
| CA2650711A1 (en) * | 2006-04-28 | 2007-11-08 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| RU2555969C1 (ru) * | 2014-07-09 | 2015-07-10 | Юлия Алексеевна Щепочкина | Керамическая масса для изготовления облицовочной плитки |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1345880A (en) * | 1971-06-18 | 1974-02-06 | Cepbepe | Pyridazine derivatives |
-
1981
- 1981-08-07 FR FR8115380A patent/FR2510998B1/fr not_active Expired
-
1982
- 1982-07-21 NO NO822509A patent/NO157861C/no unknown
- 1982-07-21 NO NO822510A patent/NO157102C/no unknown
- 1982-07-23 IE IE1779/82A patent/IE53388B1/en not_active IP Right Cessation
- 1982-07-23 IE IE1778/82A patent/IE53387B1/en not_active IP Right Cessation
- 1982-07-26 GR GR68873A patent/GR76430B/el unknown
- 1982-07-26 GR GR68868A patent/GR76429B/el unknown
- 1982-07-27 IL IL66409A patent/IL66409A/xx unknown
- 1982-07-27 IL IL66408A patent/IL66408A/xx unknown
- 1982-07-29 US US06/402,906 patent/US4508720A/en not_active Expired - Fee Related
- 1982-07-29 AU AU86554/82A patent/AU548931B2/en not_active Ceased
- 1982-07-29 AU AU86553/82A patent/AU548930B2/en not_active Ceased
- 1982-07-30 EP EP82401424A patent/EP0074863B1/fr not_active Expired
- 1982-07-30 DE DE8282401424T patent/DE3269383D1/de not_active Expired
- 1982-07-30 AT AT82401424T patent/ATE18216T1/de not_active IP Right Cessation
- 1982-07-30 ZA ZA825512A patent/ZA825512B/xx unknown
- 1982-07-30 AT AT82401425T patent/ATE12227T1/de not_active IP Right Cessation
- 1982-07-30 ZA ZA825513A patent/ZA825513B/xx unknown
- 1982-07-30 EP EP82401425A patent/EP0072726B1/fr not_active Expired
- 1982-07-30 DE DE8282401425T patent/DE3262671D1/de not_active Expired
- 1982-07-30 PT PT75350A patent/PT75350B/pt not_active IP Right Cessation
- 1982-07-30 PT PT75351A patent/PT75351B/pt not_active IP Right Cessation
- 1982-08-02 MA MA19771A patent/MA19560A1/fr unknown
- 1982-08-02 MA MA19773A patent/MA19562A1/fr unknown
- 1982-08-03 CS CS825800A patent/CS229941B2/cs unknown
- 1982-08-03 CS CS825799A patent/CS229940B2/cs unknown
- 1982-08-04 EG EG82474A patent/EG15747A/xx active
- 1982-08-04 EG EG473/82A patent/EG15788A/xx active
- 1982-08-06 CA CA000408843A patent/CA1174240A/en not_active Expired
- 1982-08-06 OA OA57767A patent/OA07175A/xx unknown
- 1982-08-06 DK DK354482A patent/DK148795C/da not_active IP Right Cessation
- 1982-08-06 YU YU01718/82A patent/YU171882A/xx unknown
- 1982-08-06 DK DK354382A patent/DK148537C/da not_active IP Right Cessation
- 1982-08-06 AR AR290243A patent/AR231637A1/es active
- 1982-08-06 ES ES514794A patent/ES8305737A1/es not_active Expired
- 1982-08-06 JP JP57137833A patent/JPS5877868A/ja active Pending
- 1982-08-06 YU YU01720/82A patent/YU172082A/xx unknown
- 1982-08-06 NZ NZ201520A patent/NZ201520A/xx unknown
- 1982-08-06 CA CA000408844A patent/CA1179346A/en not_active Expired
- 1982-08-06 HU HU822545A patent/HU190028B/hu not_active IP Right Cessation
- 1982-08-06 FI FI822747A patent/FI72968C/fi not_active IP Right Cessation
- 1982-08-06 FI FI822748A patent/FI72969C/fi not_active IP Right Cessation
- 1982-08-06 SU SU823475704A patent/SU1138024A3/ru active
- 1982-08-06 HU HU822542A patent/HU189166B/hu not_active IP Right Cessation
- 1982-08-06 NZ NZ201518A patent/NZ201518A/en unknown
- 1982-08-06 PL PL1982237808A patent/PL137199B1/pl unknown
- 1982-08-06 OA OA57768A patent/OA07176A/xx unknown
- 1982-08-06 JP JP57137832A patent/JPS5877867A/ja active Granted
- 1982-08-06 ES ES514795A patent/ES514795A0/es active Granted
- 1982-08-06 PL PL1982237809A patent/PL130647B1/pl unknown
- 1982-08-06 AR AR290242A patent/AR231441A1/es active
- 1982-08-06 PH PH27679A patent/PH18545A/en unknown
- 1982-08-06 SU SU823476698A patent/SU1140685A3/ru active
- 1982-08-07 KR KR8203558A patent/KR880001624B1/ko not_active Expired
- 1982-08-07 KR KR8203557A patent/KR890001569B1/ko not_active Expired
- 1982-08-09 DD DD82242359A patent/DD202549A5/de unknown
- 1982-08-09 DD DD82242356A patent/DD202715A5/de unknown
Non-Patent Citations (1)
| Title |
|---|
| 1. Патент FR № 2141697, кл. А 61 К 27/00, опублик. 1973. 2. Вейганд-Хильгетаг. Методы эксперимента в органической химии. М., Хими , 1969, с. 413-419. * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1138024A3 (ru) | Способ получени аминопроизводных пиридазина | |
| SU843746A3 (ru) | Способ получени аминотиазоловили иХ КиСлОТНО-АддиТиВНыХ СОлЕй | |
| US4146647A (en) | Substituted phenyl-amidines | |
| CA1300619C (en) | 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine, various derivatives thereof, processes for the preparation of these compounds, medicaments containing them, and their use | |
| PL83097B1 (OSRAM) | ||
| JPS5838262A (ja) | ４−メチル６−フエニルピリダジン誘導体 | |
| US3268582A (en) | Phenylalkyl-carboxylic acid amides | |
| Lalezari et al. | Synthesis of 1‐aryl‐1, 2, 3‐triazole‐4, 5‐dimethanol‐4, 5‐bis (isopropylcarbamates) as potential antineoplastic agents | |
| GB2030985A (en) | Substituted furans | |
| US3166562A (en) | Novel nicotinic acid phenyl-ethylamides and process for preparing them | |
| US4603019A (en) | N-(methoxyphenacyl)-amine derivatives | |
| US4421754A (en) | Syndonimine derivatives, process for production thereof, and use thereof | |
| EP0146838B1 (en) | (alkylsulfonyl)methanesulfonates as anticancer agents | |
| US4367239A (en) | Nitrosourea derivatives, pharmaceutical compositions thereof and method of preparation | |
| US2670373A (en) | Halogenated n-aryl-n-dialkylaminoalkyl-arylcarboxamides | |
| US3895057A (en) | Aminoalkanols and their pharmaceutically acceptable acid-addition salts, and production thereof | |
| PL82037B1 (OSRAM) | ||
| US2695293A (en) | N, n'-substituted diamine compounds and method of making the same | |
| US2490937A (en) | Aminoalkyl-phenyl lactones | |
| US4423076A (en) | 1-Branched-alkyl-3-(2-haloethyl)-3-nitrosoureas as novel antitumor agents | |
| KR850000210B1 (ko) | 옥사졸린의 제조방법 | |
| US3317526A (en) | Omega-tertiaryamino butynol-1-phenylcycloalkane carboxylates | |
| US3373163A (en) | N-methyl-piperazides of alicyclic and heterocyclic carboxylic acids | |
| RU2032670C1 (ru) | S-(1-метилпиридиний-3-метил)-n,n`-диметилтиурония дийодид, проявляющий радиозащитную активность | |
| DE3014738C2 (OSRAM) |